These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21822306)

  • 1. Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells.
    Jennewein C; Karl S; Baumann B; Micheau O; Debatin KM; Fulda S
    Oncogene; 2012 Mar; 31(11):1468-74. PubMed ID: 21822306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.
    Trauzold A; Wermann H; Arlt A; Schütze S; Schäfer H; Oestern S; Röder C; Ungefroren H; Lampe E; Heinrich M; Walczak H; Kalthoff H
    Oncogene; 2001 Jul; 20(31):4258-69. PubMed ID: 11464292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS; Chang I; Kim JY; Choi KH; Lee MS
    Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
    Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verrucarin A enhances TRAIL-induced apoptosis via NF-κB-mediated Fas overexpression.
    Jayasooriya RG; Moon DO; Yun SG; Choi YH; Asami Y; Kim MO; Jang JH; Kim BY; Ahn JS; Kim GY
    Food Chem Toxicol; 2013 May; 55():1-7. PubMed ID: 23306790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
    Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB.
    Nagaki M; Naiki T; Brenner DA; Osawa Y; Imose M; Hayashi H; Banno Y; Nakashima S; Moriwaki H
    Hepatology; 2000 Dec; 32(6):1272-9. PubMed ID: 11093734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
    Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
    Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
    Gupta P; Dixit D; Sen E
    Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
    Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
    Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
    Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
    J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
    Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
    Guseva NV; Taghiyev AF; Sturm MT; Rokhlin OW; Cohen MB
    Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway.
    Wang X; Ju W; Renouard J; Aden J; Belinsky SA; Lin Y
    Cancer Res; 2006 Jan; 66(2):1089-95. PubMed ID: 16424045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.